PLRX - Pliant Therapeutics  - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

PLRX is currently covered by 12 analysts with an average price target of $38.05. This is a potential upside of $26.15 (219.75%) from yesterday's end of day stock price of $11.9.

Pliant Therapeutics 's activity chart (see below) currently has 9 price targets and 62 ratings on display. The stock rating distribution of PLRX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 15.45% with an average time for these price targets to be met of 74.36 days.

Highest price target for PLRX is $63, Lowest price target is $34, average price target is $38.05.

Most recent stock forecast was given by BRIAN ABRAHAMS from RBC on 28-Feb-2024. First documented stock forecast 29-Jun-2020.

Currently out of the existing stock ratings of PLRX, 54 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

50

$38.1 (320.17%)

53

1 months 28 days ago

0/10 (0%)

$33.38 (200.84%)

Buy

48

$36.1 (303.36%)

48

1 months 28 days ago

0/12 (0%)

$31.38 (188.81%)

Buy

38

$26.1 (219.33%)

38

1 months 28 days ago

0/9 (0%)

$21.38 (128.64%)

Buy

34

$22.1 (185.71%)

45

5 months 15 days ago

1/3 (33.33%)

$20.17 (145.84%)

43

Buy

47

$35.1 (294.96%)

48

5 months 15 days ago

0/5 (0%)

$33.17 (239.84%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PLRX (Pliant Therapeutics ) average time for price targets to be met?

On average it took 74.36 days on average for the stock forecasts to be realized with a an average price target met ratio 15.45

Which analyst has the current highest performing score on PLRX (Pliant Therapeutics ) with a proven track record?

YASMEEN RAHIMI

Which analyst has the most public recommendations on PLRX (Pliant Therapeutics )?

Yasmeen Rahimi works at PIPER SANDLER and has 4 price targets and 4 ratings on PLRX

Which analyst is the currently most bullish on PLRX (Pliant Therapeutics )?

Pete Stavropoulos with highest potential upside - $51.1

Which analyst is the currently most reserved on PLRX (Pliant Therapeutics )?

Alex Thompson with lowest potential downside - $22.1

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?